Multiple Myeloma: A POCN Center of Excellence – Resources Supporting Excellence in Clinical Practice

Multiple Myeloma Resources
Chosen by Advanced
Practice Providers

Clinical guidelines
Patient support and education resources
Research updates

Early Daratumumab Monotherapy Delays Progression in High-Risk Smoldering Myeloma

Researchers of the phase 3 Aquila study presented at the 66th ASH Annual Meeting and showed that daratumumab (D) monotherapy significantly delays progression in patients with high-risk smoldering...

CURATED BY: Laura J. Zitella,
MS, RN, ACNP-BC, AOCN

Laura J. Zitella

MS, RN, ACNP-BC, AOCN
Nurse Practitioner, Associate Clinical Professor, University of California San Francisco

Balancing Efficacy and Safety: Managing Adverse Events With IMiDs in Multiple Myeloma

Immunomodulatory drugs (IMiDs) such as thalidomide, lenalidomide, and pomalidomide are integral to multiple myeloma (MM) treatment, improving survival and quality of life....

CURATED BY:
Danielle Roberts,
MS, MMSc, PA-C

Comprehensive Advances in Multiple Myeloma: From Diagnosis to Emerging Therapies

Multiple myeloma is a plasma cell cancer that often develops from precursor conditions like monoclonal gammopathy of undetermined significance or smoldering multiple myeloma (SMM)....

CURATED BY:
Danielle Roberts,
MS, MMSc, PA-C

Interconnected Burdens: Fatigue, Sleep, Mood, and Function in Newly Diagnosed Multiple Myeloma

Patients newly diagnosed with multiple myeloma (MM) often present with anemia, fatigue, sleep disturbances, pain, and mood disruption—all of which impact quality of life and functional performance....

CURATED BY:
Jill N. Burke,
CNP, DipACLM

Physician Associate and Nurse Practitioner Contributors to the Multiple Myeloma Center of Excellence

POCN’s Multiple Myeloma Center of Excellence is curated by practicing clinical physician associates and nurse practitioners who review and select resources that are the most useful to their peers. They provide their expertise by hand-picking the latest content for advanced practice providers.

Donna D. Catamero,

ANP-BC, OCN, CCRC
Associate Director, Myeloma Research, Icahn School of Medicine at Mount Sinai

Laura J. Zitella,

MS, RN, ACNP-BC, AOCN
Nurse Practitioner, Associate Clinical Professor, University of California San Francisco

Jill N. Burke,

CNP, DipACLM
Nurse Practitioner, Massachusetts General Hospital

Danielle Roberts,

MS, MMSc, PA-C
Associate Chief of Education, Winship Cancer Institute of Emory University

Early Daratumumab Monotherapy Delays Progression in High-Risk Smoldering Myeloma

Laura J. Zitella

Balancing Efficacy and Safety: Managing Adverse Events With IMiDs in Multiple Myeloma

Comprehensive Advances in Multiple Myeloma: From Diagnosis to Emerging Therapies

Interconnected Burdens: Fatigue, Sleep, Mood, and Function in Newly Diagnosed Multiple Myeloma

Physician Associate and Nurse Practitioner Contributors to the Multiple Myeloma Center of Excellence

Provided by an unrestricted grant from

© 2025 POCN—an IQVIA business. All Rights Reserved.

Share